Irregular heart rate can be detected with a camera-based monitoring technology.
ID
Bron
Verkorte titel
Aandoening
- Hartritmestoornissen
Aandoening
Atrial fibrillation
Betreft onderzoek met
Ondersteuning
Onderzoeksproduct en/of interventie
- Overige
Uitkomstmaten
Primaire uitkomstmaten
Validity of camera based monitoring to detect irregular heartrate in comparison with ECG
Achtergrond van het onderzoek
Forty percent of unanticipated deaths and deteriorations in hospitals occur in low- acuity departments. This alarming figure reflects the limited degree to which the cardiorespiratory status of patients is monitored in these departments, due to the obtrusiveness and expense of existing monitoring technologies, as well as the unpractically high clinical workload and cost that deployment of such technologies would entail. The FORSEE-project explores video monitoring of the cardiorespiratory status of the patient as an innovative unobtrusive method that could eventually aid to reduce workload for staff and better predict deterioration of adverse events. The main objective of this study is to determine the validity of camera based monitoring to detect irregular heart rate in comparison with ECG. Secondary objectives are the validity of the camera based monitoring technology to detect respiratory rate, oxygen saturation and different activity levels. Another secondary objective is to evaluate user and patient experience. This is an observational study, subjects will be asked to add the contactless camera set-up to the standard procedure. The main endpoint is the correspondence between the camera based heart rate and other vital signs in comparison with the standard contact sensors. All data will be analysed retrospectively and the data collected will be used for algorithm development.
Doel van het onderzoek
Irregular heart rate can be detected with a camera-based monitoring technology.
Onderzoeksopzet
Endpoint correspondence between the camera based heart rate and other vital signs in comparison with the standard contact sensors: T0 Camera-based vital signs and reference signals will be collected at least 10 minutes before, during and at least 10 minutes after the cardioversion. This data will be analyzed retrospectively, no clinical decisions will be based on this study data. Endpoint patient experience: T0 Questionnaires will be handed out after the cardioversion and patients will be asked to complete the questionnaire during their hospital stay. T1: When all 48 patients have participated in the trial, a selection of patients will be asked to participate in a focus group (within 3 months after data collection). Endpoint user experience: T0: All involved healthcare providers will be asked to complete a questionnaire about their experience with the video monitoring technology after the cardioversion. T1: When all 48 patients have participated in the trial, a selection of healthcare providers will be asked to participate in a focus group.
Publiek
Wetenschappelijk
Leeftijd
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- In staat om consent formulier te tekenen
- Patienten met atriumfibrilleren gepland voor cardioversie
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Mentale beperking
- Taalbarrière
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Huispostnr D01.343
Postbus 85500
3508 GA Utrecht
088 755 6376
metc@umcutrecht.nl
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL9854 |
Ander register | METC MMC : N21.039 |